<p>APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the &micro;-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy</p>

Original Research

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

Total article views		HTML views	PDF downloads	Totals
14,749	Dovepress*	11,090+	1,587	12,677
	PubMed Central*	3,659	1,352	5,011
	Totals	14,749	2,939	17,688
*Since 11 March 2019

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
14	0	0	0	4	10